{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:12:41Z","timestamp":1783901561933,"version":"3.55.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0508904"],"award-info":[{"award-number":["2023ZD0508904"]}]},{"name":"Hubei Key Laboratory of Central Nervous System Tumor and Intervention","award":["ZZYKF202602"],"award-info":[{"award-number":["ZZYKF202602"]}]},{"name":"Postdoctoral Scientific Research Foundation of General Hospital of Central Theater Command","award":["BSH069"],"award-info":[{"award-number":["BSH069"]}]},{"name":"Key Project of 987th Hospital","award":["2024Djbqyy-06"],"award-info":[{"award-number":["2024Djbqyy-06"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300931"],"award-info":[{"award-number":["82300931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08253-4","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:15:24Z","timestamp":1778912124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metrnl in diabetes and its complications: divergent evidence and translational prospects"],"prefix":"10.1186","volume":"24","author":[{"given":"Shengwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"8253_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14:149\u201356.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8253_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.tem.2024.12.006","volume":"36","author":"PS Hamblin","year":"2025","unstructured":"Hamblin PS, Russell AW, Talic S, Zoungas S. The growing range of complications of diabetes mellitus. Trends Endocrinol Metab. 2025;36:943\u201354.","journal-title":"Trends Endocrinol Metab"},{"key":"8253_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.tem.2025.01.004","volume":"36","author":"L Sandforth","year":"2025","unstructured":"Sandforth L, Kullmann S, Sandforth A, Fritsche A, Jumpertz-von Schwartzenberg R, Stefan N, et al. Prediabetes remission to reduce the global burden of type 2 diabetes. Trends Endocrinol Metab. 2025;36:899\u2013916.","journal-title":"Trends Endocrinol Metab"},{"key":"8253_CR4","doi-asserted-by":"publisher","first-page":"e082071","DOI":"10.1136\/bmj-2024-082071","volume":"390","author":"A Agarwal","year":"2025","unstructured":"Agarwal A, Mustafa R, Manja V, Agoritsas T, Macdonald H, Li S, et al. Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline. BMJ. 2025;390:e082071.","journal-title":"BMJ"},{"key":"8253_CR5","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202406180","volume":"177","author":"AL Crawford","year":"2024","unstructured":"Crawford AL, Laiteerapong N. Type 2 Diabetes. Ann Intern Med. 2024;177:ITC81\u201396.","journal-title":"Ann Intern Med"},{"key":"8253_CR6","doi-asserted-by":"crossref","unstructured":"Wang B, Li X, Gao X. Meteorin-beta: a novel biomarker and therapeutic target on its way to the regulation of human diseases. Int J Mol Sci. 2025;26.","DOI":"10.3390\/ijms26104485"},{"key":"8253_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s10020-025-01150-4","volume":"31","author":"DX Chen","year":"2025","unstructured":"Chen DX, Feng YY, Wang HY, Lu CH, Liu DZ, Gong C, et al. Metrnl ameliorates myocardial ischemia-reperfusion injury by activating AMPK-mediated M2 macrophage polarization. Mol Med. 2025;31:98.","journal-title":"Mol Med"},{"key":"8253_CR8","doi-asserted-by":"publisher","first-page":"1098570","DOI":"10.3389\/fimmu.2023.1098570","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Gao Z, Sun T, Zhang S, Yang S, Zheng M, et al. Meteorin-like\/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies. Front Immunol. 2023;14:1098570.","journal-title":"Front Immunol"},{"key":"8253_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/all.16150","volume":"80","author":"D Huang","year":"2025","unstructured":"Huang D, Liu X, Gao X, Choi CK, Giglio G, Farah L, et al. Meteorin-like protein\/METRNL\/Interleukin-41 ameliorates atopic dermatitis-like inflammation. Allergy. 2025;80:474\u201388.","journal-title":"Allergy"},{"key":"8253_CR10","doi-asserted-by":"crossref","unstructured":"Alizadeh H. Dual role of Metrnl: exercise-induced benefits and potential cancer implications. J Immunother Cancer. 2025;13.","DOI":"10.1136\/jitc-2025-011666"},{"key":"8253_CR11","doi-asserted-by":"publisher","first-page":"e70371","DOI":"10.1111\/jcmm.70371","volume":"29","author":"M Xu","year":"2025","unstructured":"Xu M, Liu X, Lu L, Li Z. Metrnl and Cardiomyopathies: From Molecular Mechanisms to Therapeutic Insights. J Cell Mol Med. 2025;29:e70371.","journal-title":"J Cell Mol Med"},{"key":"8253_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/13813455.2025.2497272","volume":"131","author":"H Alizadeh","year":"2025","unstructured":"Alizadeh H, Parsaeifar A, Mohammadi Mirzaei R. Meteorin-like protein (Metrnl): a key exerkine in exercise-mediated cardiovascular health. Arch Physiol Biochem. 2025;131:713\u201327.","journal-title":"Arch Physiol Biochem"},{"key":"8253_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12944-024-02357-w","volume":"23","author":"R Han","year":"2024","unstructured":"Han R, Huang H, Zhu J, Jin X, Wang Y, Xu Y, et al. Adipokines and their potential impacts on susceptibility to myocardial ischemia\/reperfusion injury in diabetes. Lipids Health Dis. 2024;23:372.","journal-title":"Lipids Health Dis"},{"key":"8253_CR14","doi-asserted-by":"publisher","first-page":"108730","DOI":"10.1016\/j.pharmthera.2024.108730","volume":"263","author":"ZW Miao","year":"2024","unstructured":"Miao ZW, Chen J, Chen CX, Zheng SL, Zhao HY, Miao CY. Metrnl as a secreted protein: Discovery and cardiovascular research. Pharmacol Ther. 2024;263:108730.","journal-title":"Pharmacol Ther"},{"key":"8253_CR15","doi-asserted-by":"publisher","first-page":"155952","DOI":"10.1016\/j.cyto.2022.155952","volume":"157","author":"H Alizadeh","year":"2022","unstructured":"Alizadeh H. Meteorin-like protein (Metrnl): A metabolic syndrome biomarker and an exercise mediator. Cytokine. 2022;157:155952.","journal-title":"Cytokine"},{"key":"8253_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41401-020-00529-9","volume":"41","author":"ZW Miao","year":"2020","unstructured":"Miao ZW, Hu WJ, Li ZY, Miao CY. Involvement of the secreted protein Metrnl in human diseases. Acta Pharmacol Sin. 2020;41:1525\u201330.","journal-title":"Acta Pharmacol Sin"},{"key":"8253_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clim.2014.11.006","volume":"156","author":"I Ushach","year":"2015","unstructured":"Ushach I, Burkhardt AM, Martinez C, Hevezi PA, Gerber PA, Buhren BA, et al. METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol. 2015;156:119\u201327.","journal-title":"Clin Immunol"},{"key":"8253_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1399-0004.2009.01203.x","volume":"76","author":"C Surace","year":"2009","unstructured":"Surace C, Piazzolla S, Sirleto P, Digilio MC, Roberti MC, Lombardo A, et al. Mild ring 17 syndrome shares common phenotypic features irrespective of the chromosomal breakpoints location. Clin Genet. 2009;76:256\u201362.","journal-title":"Clin Genet"},{"key":"8253_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08977194.2022.2032689","volume":"39","author":"H Alizadeh","year":"2021","unstructured":"Alizadeh H. Myokine-mediated exercise effects: the role of myokine meteorin-like hormone (Metrnl). Growth Factors. 2021;39:71\u20138.","journal-title":"Growth Factors"},{"key":"8253_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.apsb.2022.12.008","volume":"13","author":"S Zheng","year":"2023","unstructured":"Zheng S, Li Z, Song J, Wang P, Xu J, Hu W, et al. Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis. Acta Pharm Sin B. 2023;13:1568\u201387.","journal-title":"Acta Pharm Sin B"},{"key":"8253_CR21","doi-asserted-by":"crossref","unstructured":"Velikova T, Bakopoulou K, Gulinac M, Manova E, Valkov H, Miteva D, et al. Emerging therapeutic and inflammation biomarkers: the role of meteorin-like (Metrnl) and follistatin-Like 1 (FSTL1) in inflammatory diseases. Int J Mol Sci. 2025;26.","DOI":"10.3390\/ijms26199711"},{"key":"8253_CR22","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1080\/07391102.2023.2220804","volume":"42","author":"SS Shankar","year":"2024","unstructured":"Shankar SS, Banarjee R, Jathar SM, Rajesh S, Ramasamy S, Kulkarni MJ. De novo structure prediction of meteorin and meteorin-like protein for identification of domains, functional receptor binding regions, and their high-risk missense variants. J Biomol Struct Dyn. 2024;42:4522\u201336.","journal-title":"J Biomol Struct Dyn"},{"key":"8253_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/aps.2016.9","volume":"37","author":"SL Zheng","year":"2016","unstructured":"Zheng SL, Li ZY, Song J, Liu JM, Miao CY. Metrnl: a secreted protein with new emerging functions. Acta Pharmacol Sin. 2016;37:571\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"8253_CR24","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1242\/jcs.063784","volume":"123","author":"HS Lee","year":"2010","unstructured":"Lee HS, Han J, Lee SH, Park JA, Kim KW. Meteorin promotes the formation of GFAP-positive glia via activation of the Jak-STAT3 pathway. J Cell Sci. 2010;123:1959\u201368.","journal-title":"J Cell Sci"},{"key":"8253_CR25","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/s42255-025-01355-1","volume":"7","author":"X Wang","year":"2025","unstructured":"Wang X, Moore MP, Shi H, Xiao Y, Zhang J, Faccioli LAP, et al. A non-apoptotic caspase-8-meteorin pathway in hepatocytes promotes MASH fibrosis. Nat Metab. 2025;7:2067\u201382.","journal-title":"Nat Metab"},{"key":"8253_CR26","doi-asserted-by":"crossref","unstructured":"Zhao R, Qi Y, Li P, Zhang Z, Chen Y, Wu X, et al. Metrnl in health and disease: tissue-specific actions and signaling networks. Apoptosis. 2026;31.","DOI":"10.1007\/s10495-026-02312-3"},{"key":"8253_CR27","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/j.pain.0000000000003523","volume":"166","author":"I Sankaranarayanan","year":"2025","unstructured":"Sankaranarayanan I, Kume M, Mohammed A, Mwirigi JM, Inturi NN, Munro G, et al. Persistent changes in the dorsal root ganglion nociceptor translatome governs hyperalgesic priming in mice: roles of GPR88 and Meteorin. Pain. 2025;166:1395\u2013405.","journal-title":"Pain"},{"key":"8253_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fncel.2016.00177","volume":"10","author":"JL Wright","year":"2016","unstructured":"Wright JL, Ermine CM, Jorgensen JR, Parish CL, Thompson LH. Over-Expression of Meteorin Drives Gliogenesis Following Striatal Injury. Front Cell Neurosci. 2016;10:177.","journal-title":"Front Cell Neurosci"},{"key":"8253_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.13791","volume":"173","author":"R Shi","year":"2024","unstructured":"Shi R, He M, Peng Y, Xia X. Homotherapy for heteropathy: Interleukin-41 and its biological functions. Immunology. 2024;173:1\u201313.","journal-title":"Immunology"},{"key":"8253_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cns.12219","volume":"20","author":"ZY Li","year":"2014","unstructured":"Li ZY, Zheng SL, Wang P, Xu TY, Guan YF, Zhang YJ, et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci Ther. 2014;20:344\u201354.","journal-title":"CNS Neurosci Ther"},{"key":"8253_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/a-2502-8712","volume":"133","author":"X Meng","year":"2025","unstructured":"Meng X, Pu Z, He J, Li Q, Xie Y. Metrnl Ameliorates Ferroptosis in Model of Diabetic Foot Ulcer Through the Inhibition of Mitochondrial Damage via LKB1\/AMPK Signaling. Exp Clin Endocrinol Diabetes. 2025;133:120\u201332.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"8253_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"8253_CR33","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00125-025-06459-7","volume":"68","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Hu L, Zhuang R, Song L, Chang X, Liu L, et al. METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice. Diabetologia. 2025;68:1769\u201388.","journal-title":"Diabetologia"},{"key":"8253_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","volume":"157","author":"RR Rao","year":"2014","unstructured":"Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014;157:1279\u201391.","journal-title":"Cell"},{"key":"8253_CR35","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.2337\/db15-0274","volume":"64","author":"ZY Li","year":"2015","unstructured":"Li ZY, Song J, Zheng SL, Fan MB, Guan YF, Qu Y, et al. Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARgamma Signaling. Diabetes. 2015;64:4011\u201322.","journal-title":"Diabetes"},{"key":"8253_CR36","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/febs.15301","volume":"287","author":"JO Lee","year":"2020","unstructured":"Lee JO, Byun WS, Kang MJ, Han JA, Moon J, Shin MJ, et al. The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKalpha2. FEBS J. 2020;287:2087\u2013104.","journal-title":"FEBS J"},{"key":"8253_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2337\/db22-0680","volume":"72","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liu L, Jin B, Wu Y, Xu L, Chang X, et al. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy. Diabetes. 2023;72:611\u201326.","journal-title":"Diabetes"},{"key":"8253_CR38","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2337\/db23-0173","volume":"72","author":"L Song","year":"2023","unstructured":"Song L, Chang X, Hu L, Liu L, Wang G, Huang Y, et al. Accelerating Wound Closure With Metrnl in Normal and Diabetic Mouse Skin. Diabetes. 2023;72:1692\u2013706.","journal-title":"Diabetes"},{"key":"8253_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jare.2022.10.014","volume":"51","author":"QB Lu","year":"2023","unstructured":"Lu QB, Ding Y, Liu Y, Wang ZC, Wu YJ, Niu KM, et al. Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS\/STING signaling dependent on LKB1\/AMPK\/ULK1-mediated autophagy. J Adv Res. 2023;51:161\u201379.","journal-title":"J Adv Res"},{"key":"8253_CR40","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/aps.2016.70","volume":"37","author":"ZY Li","year":"2016","unstructured":"Li ZY, Fan MB, Zhang SL, Qu Y, Zheng SL, Song J, et al. Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides. Acta Pharmacol Sin. 2016;37:1458\u201366.","journal-title":"Acta Pharmacol Sin"},{"key":"8253_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41420-025-02457-1","volume":"11","author":"ZY Li","year":"2025","unstructured":"Li ZY, Luo HY, Xu F, Xu Y, Ma CH, Zhang SL, et al. Metrnl protects intestinal barrier function by regulating tight junctions via the IKKbeta\/IkappaBalpha\/NFkappaB\/MLCK\/MLC signaling pathway. Cell Death Discov. 2025;11:155.","journal-title":"Cell Death Discov"},{"key":"8253_CR42","doi-asserted-by":"publisher","first-page":"115246","DOI":"10.1016\/j.celrep.2025.115246","volume":"44","author":"L Song","year":"2025","unstructured":"Song L, Huang Y, Liu L, Chang X, Hu L, Wang G, et al. Meteorin-like alleviates hepatic steatosis by regulating hepatic triglyceride secretion and fatty acid oxidation. Cell Rep. 2025;44:115246.","journal-title":"Cell Rep"},{"key":"8253_CR43","first-page":"700","volume":"62","author":"A Alizadeh","year":"2022","unstructured":"Alizadeh A, Alizadeh H. Downhill running exercise increases circulating level of myokine meteorin-like hormone in humans. J Sports Med Phys Fit. 2022;62:700\u20134.","journal-title":"J Sports Med Phys Fit"},{"key":"8253_CR44","doi-asserted-by":"publisher","first-page":"e14540","DOI":"10.14814\/phy2.14540","volume":"8","author":"Y Amano","year":"2020","unstructured":"Amano Y, Nonaka Y, Takeda R, Kano Y, Hoshino D. Effects of electrical stimulation-induced resistance exercise training on white and brown adipose tissues and plasma meteorin-like concentration in rats. Physiol Rep. 2020;8:e14540.","journal-title":"Physiol Rep"},{"key":"8253_CR45","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.2174\/1381612826666201007163930","volume":"26","author":"Q Wu","year":"2020","unstructured":"Wu Q, Dan YL, He YS, Xiang K, Hu YQ, Zhao CN, et al. Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis. Curr Pharm Des. 2020;26:5732\u20138.","journal-title":"Curr Pharm Des"},{"key":"8253_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/13813455.2021.1899239","volume":"129","author":"GA Ferns","year":"2023","unstructured":"Ferns GA, Fekri K, Shahini Shams Abadi M, Banitalebi Dehkordi M, Arjmand MH. A meta-analysis of the relationship between serums metrnl-like protein\/subfatin and risk of type 2 diabetes mellitus and coronary artery disease. Arch Physiol Biochem. 2023;129:1084\u201390.","journal-title":"Arch Physiol Biochem"},{"key":"8253_CR47","doi-asserted-by":"crossref","unstructured":"Xie J, Jiang Y, Yao J, Feng B, Sun X. Relationship between Meteorin-like protein and type 2 diabetes mellitus: an update and meta-analysis. Endocr Connect. 2025;14.","DOI":"10.1530\/EC-25-0452"},{"key":"8253_CR48","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.abn3027","volume":"376","author":"MR Reboll","year":"2022","unstructured":"Reboll MR, Klede S, Taft MH, Cai CL, Field LJ, Lavine KJ, et al. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase. Science. 2022;376:1343\u20137.","journal-title":"Science"},{"key":"8253_CR49","first-page":"1","volume":"50","author":"TW Jung","year":"2018","unstructured":"Jung TW, Lee SH, Kim HC, Bang JS, Abd El-Aty AM, Hacimuftuoglu A, et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARdelta-dependent pathways in skeletal muscle of mice. Exp Mol Med. 2018;50:1\u201311.","journal-title":"Exp Mol Med"},{"key":"8253_CR50","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00125-025-06426-2","volume":"68","author":"JM Costa-Junior","year":"2025","unstructured":"Costa-Junior JM, Coomans de Brachene A, Musuaya AE, Zimath PL, Martin-Vazquez E, Oliveira JG, et al. Exercise-induced meteorin-like protein protects human pancreatic beta cells from cytokine-induced apoptosis. Diabetologia. 2025;68:1524\u20139.","journal-title":"Diabetologia"},{"key":"8253_CR51","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.immuni.2024.07.003","volume":"57","author":"CM Jackson","year":"2024","unstructured":"Jackson CM, Pant A, Dinalankara W, Choi J, Jain A, Nitta R, et al. The cytokine Meteorin-like inhibits anti-tumor CD8(+) T cell responses by disrupting mitochondrial function. Immunity. 2024;57:1864\u2013e779.","journal-title":"Immunity"},{"key":"8253_CR52","doi-asserted-by":"publisher","first-page":"eadw8481","DOI":"10.1126\/scitranslmed.adw8481","volume":"18","author":"J Liu","year":"2026","unstructured":"Liu J, Ding H, Tan W, Yu R, Li Y, Liu Y, et al. Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans. Sci Transl Med. 2026;18:eadw8481.","journal-title":"Sci Transl Med"},{"key":"8253_CR53","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(24)00127-X","volume":"12","author":"M Abdul-Ghani","year":"2024","unstructured":"Abdul-Ghani M, Maffei P, DeFronzo RA. Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes. Lancet Diabetes Endocrinol. 2024;12:674\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8253_CR54","doi-asserted-by":"publisher","first-page":"e0309338","DOI":"10.1371\/journal.pone.0309338","volume":"19","author":"L Lin","year":"2024","unstructured":"Lin L, Huang S, Lin X, Liu X, Xu X, Li C, et al. Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-beta1\/Smads signaling pathway: A potential therapeutic target. PLoS ONE. 2024;19:e0309338.","journal-title":"PLoS ONE"},{"key":"8253_CR55","doi-asserted-by":"publisher","first-page":"e0204180","DOI":"10.1371\/journal.pone.0204180","volume":"13","author":"M Dadmanesh","year":"2018","unstructured":"Dadmanesh M, Aghajani H, Fadaei R, Ghorban K. Lower serum levels of Meteorin-like\/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. PLoS ONE. 2018;13:e0204180.","journal-title":"PLoS ONE"},{"key":"8253_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.diabres.2017.10.005","volume":"135","author":"JH Lee","year":"2018","unstructured":"Lee JH, Kang YE, Kim JM, Choung S, Joung KH, Kim HJ, et al. Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes. Diabetes Res Clin Pract. 2018;135:7\u201310.","journal-title":"Diabetes Res Clin Pract"},{"key":"8253_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1248\/cpb.c17-00846","volume":"66","author":"SL Zheng","year":"2018","unstructured":"Zheng SL, Li ZY, Zhang Z, Wang DS, Xu J, Miao CY. Evaluation of Two Commercial Enzyme-Linked Immunosorbent Assay Kits for the Detection of Human Circulating Metrnl. Chem Pharm Bull (Tokyo). 2018;66:391\u20138.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"8253_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.diabres.2019.02.026","volume":"150","author":"HM El-Ashmawy","year":"2019","unstructured":"El-Ashmawy HM, Selim FO, Hosny TAM, Almassry HN. Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis. Diabetes Res Clin Pract. 2019;150:57\u201363.","journal-title":"Diabetes Res Clin Pract"},{"key":"8253_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/13813455.2018.1538248","volume":"126","author":"R Fadaei","year":"2020","unstructured":"Fadaei R, Dadmanesh M, Moradi N, Ahmadi R, Shokoohi Nahrkhalaji A, Aghajani H, et al. Serum levels of subfatin in patients with type 2 diabetes mellitus and its association with vascular adhesion molecules. Arch Physiol Biochem. 2020;126:335\u201340.","journal-title":"Arch Physiol Biochem"},{"key":"8253_CR60","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5603\/EP.a2020.0038","volume":"71","author":"E Onalan","year":"2020","unstructured":"Onalan E, Cavli C, Dogan Y, Onalan E, Gozel N, Buran I, et al. Low serum levels of meteorin-like\/subfatin: an indicator of diabetes mellitus and insulin resistance? Endokrynol Pol. 2020;71:397\u2013403.","journal-title":"Endokrynol Pol"},{"key":"8253_CR61","doi-asserted-by":"publisher","first-page":"108443","DOI":"10.1016\/j.diabres.2020.108443","volume":"169","author":"R Wang","year":"2020","unstructured":"Wang R, Hu D, Zhao X, Hu W. Correlation of serum meteorin-like concentrations with diabetic nephropathy. Diabetes Res Clin Pract. 2020;169:108443.","journal-title":"Diabetes Res Clin Pract"},{"key":"8253_CR62","doi-asserted-by":"crossref","unstructured":"Timurkaan M, Timurkaan ES. Two important players for Type 2 diabetes mellitus: Metrnl and Asprosin. Clin Lab. 2022;68.","DOI":"10.7754\/Clin.Lab.2021.211015"},{"key":"8253_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1515\/hmbci-2022-0037","volume":"44","author":"Y Khajebishak","year":"2023","unstructured":"Khajebishak Y, Faghfouri AH, Soleimani A, Madani S, Payahoo L. Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters. Horm Mol Biol Clin Investig. 2023;44:127\u201335.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"8253_CR64","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.diabres.2017.11.031","volume":"136","author":"HS Chung","year":"2018","unstructured":"Chung HS, Hwang SY, Choi JH, Lee HJ, Kim NH, Yoo HJ, et al. Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes. Diabetes Res Clin Pract. 2018;136:100\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"8253_CR65","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.12659\/MSM.915331","volume":"25","author":"K Wang","year":"2019","unstructured":"Wang K, Li F, Wang C, Deng Y, Cao Z, Cui Y, et al. Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance. Med Sci Monit. 2019;25:2337\u201343.","journal-title":"Med Sci Monit"},{"key":"8253_CR66","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.12659\/MSM.920222","volume":"25","author":"C Wang","year":"2019","unstructured":"Wang C, Pan Y, Song J, Sun Y, Li H, Chen L, et al. Serum Metrnl Level is Correlated with Insulin Resistance, But Not with beta-Cell Function in Type 2 Diabetics. Med Sci Monit. 2019;25:8968\u201374.","journal-title":"Med Sci Monit"},{"key":"8253_CR67","doi-asserted-by":"crossref","unstructured":"AlKhairi I, Cherian P, Abu-Farha M, Madhoun AA, Nizam R, Melhem M, et al. Increased expression of meteorin-like hormone in type 2 diabetes and obesity and its association with irisin. Cells. 2019;8.","DOI":"10.3390\/cells8101283"},{"key":"8253_CR68","first-page":"7145","volume":"26","author":"K Tuncer Kara","year":"2022","unstructured":"Tuncer Kara K, Kizil M, Cakmak E, Yildirim TT, Kilinc F, Kuloglu T, et al. Comparison of plasma and salivary meteorin-like protein levels in patients with newly diagnosed Type-2 diabetes and treated with metformin. Eur Rev Med Pharmacol Sci. 2022;26:7145\u201350.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8253_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12902-024-01616-2","volume":"24","author":"C Yao","year":"2024","unstructured":"Yao C, Zhang H, Wang L, Li J. Correlation of serum Meteorin-like (Metrnl) level with type 2 diabetic peripheral neuropathy. BMC Endocr Disord. 2024;24:83.","journal-title":"BMC Endocr Disord"},{"key":"8253_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11033-025-10427-0","volume":"52","author":"E Erdogan","year":"2025","unstructured":"Erdogan E, Yetisgen A, Keskin L, Tanriverdi ES, Benk Ugur IG. Bacteriological profile of diabetic foot ulcers and analysis of serum meteorin levels. Mol Biol Rep. 2025;52:323.","journal-title":"Mol Biol Rep"},{"key":"8253_CR71","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12886-023-03075-0","volume":"23","author":"S Gungor Kobat","year":"2023","unstructured":"Gungor Kobat S, Gul FC, Celik F, Liman Uzun S, Kobat MA, Akkoc RF, et al. Plasma and aqueous levels of subfatin, preptin and betatrophin in patients with diabetic retinopathy. BMC Ophthalmol. 2023;23:312.","journal-title":"BMC Ophthalmol"},{"key":"8253_CR72","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2147\/DMSO.S471954","volume":"17","author":"LDT Phuong","year":"2024","unstructured":"Phuong LDT, Tran Huy T, Huynh Quang T. The Plasma Levels of Protein Adiponectin (AdipoQ) and Meteorin-Like (Metrnl) in Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2024;17:2903\u20139.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"8253_CR73","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2147\/DMSO.S452055","volume":"17","author":"J Chen","year":"2024","unstructured":"Chen J, Li ZY, Xu F, Wang CQ, Li WW, Lu J, et al. Low Levels of Metrnl are Linked to the Deterioration of Diabetic Kidney Disease. Diabetes Metab Syndr Obes. 2024;17:959\u201367.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"8253_CR74","doi-asserted-by":"publisher","first-page":"101100","DOI":"10.1016\/j.gendis.2023.101100","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yuan J, Liu H, Chen J, Zou J, Zeng X, et al. Elevated meteorin-like protein from high-intensity interval training improves heart function via AMPK\/HDAC4 pathway. Genes Dis. 2024;11:101100.","journal-title":"Genes Dis"},{"key":"8253_CR75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12964-024-01767-8","volume":"22","author":"WS Dong","year":"2024","unstructured":"Dong WS, Hu C, Hu M, Gao YP, Hu YX, Li K, et al. Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases. Cell Commun Signal. 2024;22:389.","journal-title":"Cell Commun Signal"},{"key":"8253_CR76","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41574-025-01114-y","volume":"21","author":"D Accili","year":"2025","unstructured":"Accili D, Deng Z, Liu Q. Insulin resistance in type 2 diabetes mellitus. Nat Rev Endocrinol. 2025;21:413\u201326.","journal-title":"Nat Rev Endocrinol"},{"key":"8253_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J. 2022;46:15\u201337.","journal-title":"Diabetes Metab J"},{"key":"8253_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/endrev\/bnae032","volume":"46","author":"M Apostolopoulou","year":"2025","unstructured":"Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD. Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance. Endocr Rev. 2025;46:317\u201348.","journal-title":"Endocr Rev"},{"key":"8253_CR79","doi-asserted-by":"publisher","first-page":"e18264","DOI":"10.7717\/peerj.18264","volume":"12","author":"C Zhou","year":"2024","unstructured":"Zhou C, Zeng J, Gao X, Chen D, Zhu Q, Feng B, et al. Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study. PeerJ. 2024;12:e18264.","journal-title":"PeerJ"},{"key":"8253_CR80","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s40200-023-01225-1","volume":"22","author":"SM Tayebi","year":"2023","unstructured":"Tayebi SM, Golmohammadi M, Eslami R, Shakiba N, Costa PB. The Effects of Eight Weeks of Circuit Resistance Training on Serum METRNL Levels and Insulin Resistance in Individuals with Type 2 Diabetes. J Diabetes Metab Disord. 2023;22:1151\u20138.","journal-title":"J Diabetes Metab Disord"},{"key":"8253_CR81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/ijo.2017.268","volume":"42","author":"S Pellitero","year":"2018","unstructured":"Pellitero S, Piquer-Garcia I, Ferrer-Curriu G, Puig R, Martinez E, Moreno P, et al. Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery. Int J Obes (Lond). 2018;42:919\u201322.","journal-title":"Int J Obes (Lond)"},{"key":"8253_CR82","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.2337\/dc25-S015","volume":"48","author":"American Diabetes Association Professional Practice C. 15","year":"2025","unstructured":"American Diabetes Association Professional Practice C. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48:S306\u201320.","journal-title":"Diabetes Care"},{"key":"8253_CR83","doi-asserted-by":"publisher","first-page":"627147","DOI":"10.3389\/fphar.2021.627147","volume":"12","author":"W Hu","year":"2021","unstructured":"Hu W, Wang R, Sun B. Meteorin-Like Ameliorates beta Cell Function by Inhibiting beta Cell Apoptosis of and Promoting beta Cell Proliferation via Activating the WNT\/beta-Catenin Pathway. Front Pharmacol. 2021;12:627147.","journal-title":"Front Pharmacol"},{"key":"8253_CR84","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC202203150","volume":"175","author":"FZ Syed","year":"2022","unstructured":"Syed FZ. Type 1 Diabetes Mellitus. Ann Intern Med. 2022;175:ITC33\u201348.","journal-title":"Ann Intern Med"},{"key":"8253_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41574-024-01029-0","volume":"21","author":"A Grattoni","year":"2025","unstructured":"Grattoni A, Korbutt G, Tomei AA, Garcia AJ, Pepper AR, Stabler C, et al. Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead. Nat Rev Endocrinol. 2025;21:14\u201330.","journal-title":"Nat Rev Endocrinol"},{"key":"8253_CR86","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1507\/endocrj.EJ20-0351","volume":"68","author":"Z Yao","year":"2021","unstructured":"Yao Z, Lin P, Wang C, Wang K, Sun Y. Administration of metrnl delays the onset of diabetes in non-obese diabetic mice. Endocr J. 2021;68:179\u201388.","journal-title":"Endocr J"},{"key":"8253_CR87","first-page":"717","volume":"10","author":"N Aktepe","year":"2025","unstructured":"Aktepe N, Baran A, Baran MF, \u00d6Zi\u00c7 C, Karada\u011e M, Atalar MN. Phenolic Analysis and Antimicrobial Potential of Glycyrrhiza glabra L. Plant Root Extract. MAS J Appl Sci. 2025;10:717\u201327.","journal-title":"MAS J Appl Sci"},{"key":"8253_CR88","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(24)00827-4","volume":"404","author":"MF Hivert","year":"2024","unstructured":"Hivert MF, Backman H, Benhalima K, Catalano P, Desoye G, Immanuel J, et al. Pathophysiology from preconception, during pregnancy, and beyond. Lancet. 2024;404:158\u201374.","journal-title":"Lancet"},{"key":"8253_CR89","doi-asserted-by":"publisher","first-page":"e067946","DOI":"10.1136\/bmj-2021-067946","volume":"377","author":"W Ye","year":"2022","unstructured":"Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946.","journal-title":"BMJ"},{"key":"8253_CR90","doi-asserted-by":"publisher","first-page":"170277","DOI":"10.1016\/j.peptides.2020.170277","volume":"126","author":"S Yavuzkir","year":"2020","unstructured":"Yavuzkir S, Ugur K, Deniz R, Ustebay DU, Mirzaoglu M, Yardim M, et al. Maternal and umbilical cord blood subfatin and spexin levels in patients with gestational diabetes mellitus. Peptides. 2020;126:170277.","journal-title":"Peptides"},{"key":"8253_CR91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/10520295.2023.2176546","volume":"98","author":"A Yavuz","year":"2023","unstructured":"Yavuz A, Aydin MA, Ugur K, Aydin S, Senol A, Baykus Y, et al. Betatrophin, elabela, asprosin, glucagon and subfatin peptides in breast tissue, blood and milk in gestational diabetes. Biotech Histochem. 2023;98:243\u201354.","journal-title":"Biotech Histochem"},{"key":"8253_CR92","doi-asserted-by":"crossref","unstructured":"Reis YA, Firatligil FB, Aksan A, Kose C, Tolunay HE, Ustun Y. Are maternal serum subfatin levels altered in women with one abnormal glucose tolerance test value? Rev Assoc Med Bras (1992). 2024;70:e20231111.","DOI":"10.1590\/1806-9282.20231111"},{"key":"8253_CR93","doi-asserted-by":"crossref","unstructured":"Damirova S, Kale I, Ozel A, Keles A, Yalcinkaya C, Muhcu M. Investigation of serum Metrnl levels in pregnant women with gestational diabetes mellitus: a prospective non-interventional cohort study. Rev Assoc Med Bras (1992). 2024;70:e20240660.","DOI":"10.1590\/1806-9282.20240660"},{"key":"8253_CR94","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1080\/14767058.2019.1676713","volume":"34","author":"M Lappas","year":"2021","unstructured":"Lappas M. Maternal obesity and gestational diabetes decrease Metrnl concentrations in cord plasma. J Matern Fetal Neonatal Med. 2021;34:2991\u20135.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"8253_CR95","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41581-024-00827-z","volume":"20","author":"DH van Raalte","year":"2024","unstructured":"van Raalte DH, Bjornstad P, Cherney DZI, de Boer IH, Fioretto P, Gordin D, et al. Combination therapy for kidney disease in people with diabetes mellitus. Nat Rev Nephrol. 2024;20:433\u201346.","journal-title":"Nat Rev Nephrol"},{"key":"8253_CR97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-025-02585-z","volume":"24","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhan Q, Deng Z, Lin L, Feng Z, He H, et al. Does diabetes modify the triglyceride-glucose index associated with cardiovascular events and mortality? A meta-analysis of 50 cohorts involving 7,239,790 participants. Cardiovasc Diabetol. 2025;24:42.","journal-title":"Cardiovasc Diabetol"},{"key":"8253_CR98","doi-asserted-by":"publisher","first-page":"1414508","DOI":"10.3389\/fendo.2024.1414508","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Huang Q, Zhuang Y, Chen P, Lin Y. Association between Metrnl and carotid atherosclerosis in patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2024;15:1414508.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8253_CR99","doi-asserted-by":"crossref","unstructured":"Zhao HY, Jiang JB, Chen Y, Miao CY. The hMetrnl-PLGA-PEG-PLGA hydrogel facilitates skin wound healing through dual regulation on enos activity and stability. Pharmaceuticals (Basel). 2025;18.","DOI":"10.3390\/ph18081180"},{"key":"8253_CR101","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1474-4422(22)00188-0","volume":"21","author":"MA Elafros","year":"2022","unstructured":"Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 2022;21:922\u201336.","journal-title":"Lancet Neurol"},{"key":"8253_CR102","doi-asserted-by":"publisher","first-page":"e70323","DOI":"10.1002\/jbt.70323","volume":"39","author":"F Yuksel","year":"2025","unstructured":"Yuksel F, Taslidere A, Ozcan M, Tekin C, Tekin S. The Effects of Meteorin-Like Protein on Diabetic Neuropathy: In Vivo and In Vitro Model Studies. J Biochem Mol Toxicol. 2025;39:e70323.","journal-title":"J Biochem Mol Toxicol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08253-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08253-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08253-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:02:47Z","timestamp":1783900967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08253-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8253"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08253-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"882"}}